GSA Capital Partners’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-28,213
| Closed | -$567K | – | 1867 |
|
|
2025
Q2 | $567K | Sell |
28,213
-6,583
| -19% | -$127K | 0.04% | 834 |
|
|
2025
Q1 | $631K | Buy |
+34,796
| New | +$624K | 0.06% | 635 |
|
|
2022
Q4 | – | Sell |
-50,541
| Closed | -$587K | – | 1664 |
|
|
2022
Q3 | $587K | Buy |
+50,541
| New | +$693K | 0.08% | 454 |
|
|
2022
Q2 | – | Sell |
-13,037
| Closed | -$252K | – | 1590 |
|
|
2022
Q1 | $252K | Buy |
+13,037
| New | +$233K | 0.03% | 1026 |
|
|
2021
Q3 | – | Sell |
-21,635
| Closed | -$290K | – | 1598 |
|
|
2021
Q2 | $290K | Buy |
+21,635
| New | +$271K | 0.03% | 969 |
|
|
2020
Q1 | – | Sell |
-40,691
| Closed | -$576K | – | 1291 |
|
|
2019
Q4 | $576K | Buy |
40,691
+10,605
| +35% | +$130K | 0.07% | 560 |
|
|
2019
Q3 | $317K | Sell |
30,086
-29,346
| -49% | -$351K | 0.04% | 852 |
|
|
2019
Q2 | $865K | Sell |
59,432
-26,053
| -30% | -$369K | 0.1% | 306 |
|
|
2019
Q1 | $1.2M | Buy |
85,485
+10,710
| +14% | +$173K | 0.12% | 212 |
|
|
2018
Q4 | $1.3M | Sell |
74,775
-23,300
| -24% | -$378K | 0.15% | 130 |
|
|
2018
Q3 | $1.5M | Sell |
98,075
-26,800
| -21% | -$386K | 0.08% | 420 |
|
|
2018
Q2 | $1.72M | Sell |
124,875
-104,621
| -46% | -$1.57M | 0.09% | 356 |
|
|
2018
Q1 | $3.83M | Buy |
229,496
+39,296
| +21% | +$607K | 0.2% | 58 |
|
|
2017
Q4 | $2.7M | Buy |
190,200
+111,500
| +142% | +$1.49M | 0.16% | 106 |
|
|
2017
Q3 | $1.11M | Buy |
+78,700
| New | +$1.04M | 0.08% | 448 |
|
|
2017
Q2 | – | Sell |
-20,400
| Closed | -$282K | – | 1799 |
|
|
2017
Q1 | $282K | Sell |
20,400
-27,656
| -58% | -$326K | 0.02% | 1412 |
|
|
2016
Q4 | $514K | Buy |
48,056
+2,895
| +6% | +$30.4K | 0.03% | 976 |
|
|
2016
Q3 | $496K | Buy |
+45,161
| New | +$527K | 0.03% | 1059 |
|
|
2015
Q3 | – | Sell |
-25,087
| Closed | -$453K | – | 1878 |
|
|
2015
Q2 | $453K | Sell |
25,087
-22,330
| -47% | -$384K | 0.02% | 1410 |
|
|
2015
Q1 | $745K | Buy |
47,417
+17,900
| +61% | +$271K | 0.03% | 1113 |
|
|
2014
Q4 | $418K | Sell |
29,517
-41,720
| -59% | -$627K | 0.03% | 1058 |
|
|
2014
Q3 | $1.22M | Buy |
+71,237
| New | +$1.64M | 0.06% | 376 |
|
|
2014
Q2 | – | Sell |
-19,051
| Closed | -$475K | – | 1878 |
|
|
2014
Q1 | $475K | Buy |
+19,051
| New | +$558K | 0.03% | 815 |
|
Other funds holding INVA
SCM
SFM
GSA Capital Partners's INVA Position: Q3 2025 in Review
GSA Capital Partners sold out of Innoviva (INVA) in Q3 2025, closing a stake of 28,213 shares — an estimated $567K sold.
GSA Capital Partners first reported a position in INVA in Q1 2014 and held it in 23 quarters. The position peaked at $3.83M in Q1 2018. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.
- GSA Capital Partners reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
- GSA Capital Partners sold 28,213 Innoviva shares in Q3 2025, an estimated $567K.
- GSA Capital Partners first reported a position in Innoviva in Q1 2014 and held it in 23 quarters.
- GSA Capital Partners's Innoviva position peaked at $3.83M in Q1 2018.
- 264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.
Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.